The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from PR Newswire

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation of White River Capital, Inc. (RVR), BioMimetic Therapeutics Inc. (BMTI) , Jeffries Group, Inc. (JEF) and Provectus Pharmaceuticals, Inc. (PVCT)

Wednesday, November 21, 2012

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation of White River Capital, Inc. (RVR), BioMimetic Therapeutics Inc. (BMTI) , Jeffries Group, Inc. (JEF) and Provectus Pharmaceuticals, Inc. (PVCT)16:06 EST Wednesday, November 21, 2012NEW YORK, Nov. 21, 2012 /PRNewswire/ --  (Logo: http://photos.prnewswire.com/prnh/20120409/MM84375LOGO )White River Capital, Inc.Levi & Korsinsky is investigating the Board of Directors of White River Capital, Inc. (NYSE MKT: RVR) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company and its subsidiary, Coastal Credit, LLC, to an affiliate of Parthenon Capital Partners for $23 per share. Click here to learn more about the investigation http://zlk.9nl.com/white-river-capital-rvr.  BioMimetic Therapeutics Inc.Levi & Korsinsky is investigating the Board of Directors of BioMimetic Therapeutics Inc. (NasdaqGS: BMTI) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Wright Medical Group Inc. (NasdaqGS: WMGI) under which shareholders BioMimetic shareholders will receive $1.50 in cash and 0.2482 shares of Wright common stock for each share of BioMimetic stock they own. Click here to learn more about the investigation http://zlk.9nl.com/biomimetic-bmti.  Jeffries Group, Inc.Levi & Korsinsky is investigating the Board of Directors of Jeffries Group, Inc. (NYSE: JEF) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to its largest shareholder, Leucadia National Corp. (NYSE: LUK) under which shareholders will receive 0.81 Leucadia shares for each share of Jefferies stock they own, representing an approximate value of $17.24 per share. At least one analyst set a price target of $19.00 per Jefferies share.Click here to learn more about the investigation http://zlk.9nl.com/jefferies-group-jef, or call: 877-363-5972.Provectus Pharmaceuticals, Inc.Levi & Korsinsky, LLP is investigating Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), and its Board of Directors in connection with the compensation provided to certain of its executive officers.To get more information, click here: http://zlk.9nl.com/provectus-pharmaceuticals-pvct, or call: 877-363-5972Levi & Korsinsky is a national firm with offices in New York and Washington D.C.  The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits.  Attorney advertising. Prior results do not guarantee similar outcomes.CONTACT:     Levi & Korsinsky, LLPJoseph Levi, Esq.30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500Toll Free:  (877) 363-5972Fax: (212) 363-7171www.zlk.comSOURCE Levi & Korsinsky, LLP